Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6 Molekulare Toxikologie
Alfano D, Franco P, Vocca I, Gambi N, Pisa V, Mancini A, Caputi M, Carriero MV, Iaccarino I, Stoppelli MP (2005) The urokinase plasminogen activator and ist receptor. Thromb Haemost 93: 205–211
Ames BN, Profet M, Gold IS (1990) Nature’s chemicals and synthetic chemicals: comparative toxicology. Proc Natl Acad Sci USA 87: 7782–7786
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lan-Cet 357: 539–545
Baudouin C, Charveron M, Tarroux R, Gall Y (2002) Environmental pollutants and skin cancer. Cell Biol Toxicol 18: 341–348
Bellacosa A, Moss EG (2003) RNA repair: damage control. Curr Biol 13, R482–R484
Benchimol S, Minden MD (1998) Viruses, oncogenes, and tumor suppressor genes. In: Tannok IF, Hill, RP (eds) The basic science of oncology. 3rd edn. MacGraw-Hill, New York, pp 79–105
Berger JC, Griend DJV, Robinson VL, Hickson JA, Rinker-Schaeffer CW (2005) Metastasis suppressor genes. From gene identification to protein function and regulation. Cancer Biol Ther 4: e46–e53
Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401–410
Bernstein C, Bernstein H, Payne CM, Garewal H (2002) DNA repair/pro-apoptotic dual role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 551: 145–178
Boekelheide K (2005) Mechanisms of toxic damage to spermatogenesis. J Natl cancer Inst Monographs 34: 6–8
Bondy SC, Campbell A (2005) Developmental neurotoxicology. J Neurosci Res 81: 605–612
Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O’Reilly MS, Folkam J (2000) Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 60: 1878–1886
Budak-Alpdogan T, Banerjee D, Bertino JR (2005) Hematopoietic stem cell gene therapy with drug resistance genes. Cancer Gene Ther 12: 849–863
Burgers PM (1998) Eukaryotic DNA polymerases in DNA replication and DNA repair. Chromosoma 107: 218–227
Cabiscol E, Tamarit J, Ros J (2000) Oxidative stress in bacteria and protein damage by reactive oxygen species. Int Microbiol 3: 3–8
Campbell PM, Der CJ (2004) Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14: 105–114
Cao L (2005) Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 5: 735–743
Cech TR (2004) Beginning to understand the end of the chromosome. Cell 116:273–279
Cervantes RB, Stringer JR, Shao C, Tischfield JA, Stambrook PJ (2002) Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA 99: 3586–3590
Chatelut E, Delord JP, Canal P (2003) Toxicity patterns of cytotoxic drugs. Invest New Drugs 21: 141–148
Chauhan AJ, Johnston SL (2003) Air pollution and infection in respiratory illness. Br Med Bull 68: 95–112
Christmann M, Tomicic MT, Roos WP, Kaina B (2003) Mechanisms of human DNA repair: an update. Toxicology 193: 3–34
Costa LG, Aschner M, Vitalone A, Syversen T, Soldin OP (2004) Developmental neuropathology of environmental agents. Annu Rev Pharmacol Toxicol 44:87–110
Danesi R, Del Tacca M (2004) Hematologic toxicity of immunosuppressive treatment. Transplant Proc 36: 703–704
Dano K, Behrendt N, Hoyer-Hansen G, Johnsen M, Lund LR, Ploug M, Romer J (2005) Plasminogen activation and cancer. Thromb Haemost 93: 676–681
Descotes J (2004) Importance of immunotoxicity in safety assessment: a medical toxicologist’s perspective. Toxicol Lett 149: 103–108
Dey P (2004) Aneuploidy and malignancy: an unsolved equation. J Clin Pathol 57: 1245–1249
Dixon K, Kopras E (2004) Genetic alterations and DNA repair in human carcinogenesis. Semin Cancer Biol 14: 441–448
Djojosubroto MW, Choi YS, Lee HW, Rudolph KL (2003) Telomeres and telomerase in aging, regeneration and cancer. Mol Cells 15: 164–175
Draviam VM, **e S, Sorger PK (2004) Chromosome segregation and genomic stability. Curr Opin Genet Dev 14: 120–125
Dudas A, Chovanec M (2004) DNA double-strand break repair by homologous recombination. Mutat Res 566: 131–167
Efferth T, Fabry U, Osieka R (1995) Multidrug-Resistenz. Onkologe 1: 147–153
Efferth T, Lathan B, Volm M (1991) Selective growth inhibition of multidrugresistant CHO cells by the monoclonal antibody 265/F4. Br J Cancer 64: 87–89
Efferth T, Miyachi H, Drexler HG, Gebhart E (2002a) Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells. Blood Cells Mol dis 28: 47–56
Efferth T, Rauh R, Kahl S, Tomicic M, Bochzelt H, Tome ME, Briehl MM, Bauer R, Kaina B (2005) Molecular modes of action of cantharidin in tumor cells. Biochem Pharmacol 69: 811–818
Efferth T, Verdorfer I, Miyachi H, Sauerbrey A, Drexler HG, Chitambar CR, Haber M, Gebhart E (2002b) Genomic imbalances in drug-resistant T-cell acute lympholastic CEM leukemia cell lines. Blood Cells Mol Dis 29: 1–13
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767
Feinberg AP (2004) The epigenetics of cancer etiology. Semin Cancer Biol 14: 427–432
Feinberg AP, Cui H, Ohlsson R (2002) DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin Cancer Biol 12: 389–398
Fisher JS (2004) Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. Reproduction 127: 305–315
Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411–424
Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 6Suppl 16: 15–18
Folkman J (2003) Angiogenesis and apoptosis. Semin Cancer Biol 13: 159–167
Foulds L (1992) The experimental study of tumor progression: a review. Cancer Res 61: 759–761
Gawkrodger DJ (2004) Occupational skin cancers. Occup Med 54: 458–463
Giehl K (2005) Oncogenic Ras in tumor progression and metastasis. Biol Chem 386: 193–205
Givant-Horwitz V, Davidson, B, Reich R (2005) Laminin-induced signaling in tumor cells. Cancer Lett 223: 1–10
Grattagliano I, Portincasa P, Palmieri VO, Palasciano G (2002) Overview on the mechanisms of drug-induced liver cell death. Ann Hepatol 1: 162–168
Gunawan B, Kaplowitz (2004) Clinical perspectives on xenobiotic-induced heaptotoxicity. Drug Metabol Rev 36: 301–312
Hahn WC, Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347: 1953–1603
Hanawalt PC, Ford JM, Lloyd DR (2003) Functional characterization of global genomic DNA repair and its implications for cancer. Mutat Res 544: 107–114
Harkema JR, Wagner JG (2005) Epithelial and inflammatory responses in the airways of laboratory rats exposed to ozone and biogenic substances: enhancement of toxicant-induced airway injury. Exp Toxicol Pathol 57: 129–141
Henrich WL (2005) Nephrotoxicity of several newer agents. Kidney International 67Suppl 94: S107–S109
Hojilla CV, Mohammed FF, Khokha R (2003) Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89: 1817–1821
Hoyer PB (2001) Reproductive toxicology: current and future directions. Biochem Pharmacol 62: 1557–1564
Husgafvel-Puriainen (2004) Genotoxicity of environmental tobacco smoke: a review. Mutat Res 567: 427–445
Hussain SP, Hofseth LJ, Harris CC (2003) Radical causes of cancer. Nat Rev Cancer 3: 276–285
Jallepalli PV, Lengauer C (2001) Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 1: 109–117
Jolly C, Morimoto RI (2000) Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92: 1564–1572
Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415–428
Kahl R, Kampkotter A, Watjen W, Chovolou Y (2004) Antioxidant enzymes and apoptosis. Drug Metab Rev 36: 747–762
Kakizoe T (2003) Chemoprevention of cancer — focusing on clinical trials. Jpn j Clin Oncol 33: 421–442
Kang YJ (2001) molecular and cellular mechanisms of cardiotoxicity. Environm Health Perspect 109Suppl 1: 27–34
Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432: 316–323
Kaufmann W (2003) Current status of developmental neurotoxicity: an industry perspective. Toxicol Lett 140–141: 161–169
Kimber I, Dearman RJ (2002) Immune responses: adverse versus non-adverse effects. Toxicol Pathol 30: 54–58
Knudson AG (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1: 157–162
Kopelovich L, Crowell JA, Fay JR (2003) The epigenome as a target for cancer chemoprevention. J Natl Cancer Inst 95: 1747–1757
Kregel KC (2002) Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. Appl Physiol 92: 2177–2186
Krzystyniak K, Tryphonas H, Fournier M (1995) approaches to the evaluation of chemical-induced immunotoxicity. Environ Health Perspect 103: 17–22
Kumar S (2004) Occupational exposure associated with preproductive dysfunction. J Occup Health 46: 1–19
Kunkel TA, Erie DA (2005) DNA mismatch repair. Annu Rev Biochem 74: 681–710
Kunz BA, Straffon AF, Vonarx EJ (2000) DNA damage-induced mutation: tolerance via translesion synthesis. Mutat Res 451: 169–185
Larrey D, Pageaux GP (2005) Drug-induced acute liver failure. Eur J Gastroenterol Hepatol 17: 141–143
Lee WM (2003) Drug-induced hepatotoxicity. New Engl J Med 349: 474–485
Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396: 643–649
Lephart ED, Setchell KDR, Handa RJ, Lund TD (2004) Behavioral effects of endocrine-disrupting substances: phytoestrogens. ILAR J 45: 443–454
Lippman SM, Benner SE, Hong WK (1994) Cancer Chemoprevention. J Clin Oncol 12: 851–873
Loeb KR, Loeb LA (2000) Significance of multiple mutations in cancer. Carcinogenesis 21: 379–385
Loeb LA. A mutator phenotype in cancer. Cancer Res 61: 3230–3239
Lukas J, Lukas C, Bartek J (2004) Mammalian cell cycle checkpoints: signaling pathways and their organization in space and time. DNA repair 3: 997–1007
Luster MI, Rosenthal GJ (1993) Chemical agents and the immune response. Environ Health Perspect 100: 219–236
Mancini AJ (2004) Skin. Pediatrics 113: 1114–1119
Mareel M, Leroy A (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83: 337–376
Marhaba R, Zöller M (2004) CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211–231
Mather LE, Chang DHT (2001) Cardiotoxicity with modern local anaesthetics. Is there a safer choice? Drugs 61: 333–342
Mellon I (2005) Transcription-coupled repair: a complex affair. Mutat Res 577: 155–161
Moggs JG (2005) Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics. Toxicology 213: 177–193
Morgan GJ, Alvares GL (2005) Benzene and the hemopoietic stem cell. Chem Biol Interact 153–154: 217–222
Nagano O, Saya H (2004) Mechanism and biological significance of CD44 cleavage. Cancer Sci 95: 930–935
Nilsen H, Krokan HE (2001) Base excision repair in a network of defense and tolerance. Carcinogenesis 22: 987–998
Ohshima H, Tatemichi M, Sawa T (2003). Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417: 3–11
Okey AB, Harper PA, Grant DM, Hill RP (1998) Chemical and radiation carcinogenesis. In: Tannock IF, Hill RP (eds) The basic science of oncology. 3rd edn. McGraw-Hill, New York, pp 166–196
Paakkari I (2002) Cardiotoxicity of new antihistamines and cisapride. Toxicol Lett 127: 279–284
Polifka JE, Friedman JM (2002). Medical genetics: 1. Clinical teratology in the age of genomics. Canadian Medical association Journal 167: 265–273
Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF (2003). The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66: 1499–1503
Rabbits TH (1994) Chromosomal translocations in human cancer. Nature 372: 143–149
Rajagopolan H, Lengauer C (2004) Aneuploidy and cancer. Nature 432: 338–341
Ramnath N, Creaven PJ (2004) Matrix metalloproteinase inhibitors. Curr Oncol Rep 6: 96–102
Rier S, Foster WG (2002) Environmental dioxins and endometriosis. Toxicol Sci 70: 161–170
Ruddon RW (1995) Cancer Biology. 3rd edn. Oxford Univ Press, New York Oxford, pp 318–340
Sancar A, Lindsey-Boltz LA, Ünsal-Kacmaz K, Lin S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39–85
Schulz WA, Hatina J (2006) Epigenetics of prostate cancer: beyond DNA methylation. J Cell Mol Med 10: 100–125
Schulze-Bergkamen, Krammer PH (2004) Apoptosis in cancer — implications for therapy. Semin Oncol 31: 90–119
Schwarzl SM, Smith JC, Kaina B, Efferth T (2005) Molecular modeling of O6-methylguanine-DNA methyltransferase mutant proteins encoded by single nucleotide polymorphisms. Int J Mol Med 16: 553–557
Shackleford RE, Kaufmann WK, Paules RS (2000) Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28: 1387–1404
Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity band regulation of stress-mediated apoptosis. Antioxid Redox Signal 2004; 6: 289–300.
Shields PG (2002) Molecular epidemiology of smoking and lung cancer. Oncogene 21: 6870–6876
Shin DS, Chahwan C, Huffman JL, Tainer JA (2004) Structure and function of the double-strand break repair machinery. DNA Repair (Amst) 3: 863–873
Solhaug MJ, Bolger PM, Jose PA (2004) The develo** kidney and environmental toxins. Pediatrics 113: 1084–1091
Squire JA, Whitmore GF, Phillips RA (1998) Genetic basis of cancer. In: Tannock IF, Hill RP (eds). The basic science of oncology. McGraw-Hill, New York, pp 48–78
Sun S-Y, Hail N jr, Lotan R (2004) Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 96: 662–672
Svejstrup JQ (2002) Mechanisms of transcription-coupled DNA repair. Nat Rev Mol Cell Biol 3: 21–29
Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka, Miyasaka M (2005) Chemokines in tumor progression and metastasis. Cancer Sci 96: 317–322
Tsukamoto Y, Ikeda H (1998) Double-strand break repair mediated by DNA endjoining. Genes Cells 3: 135–144
Volm M, Mattern J, Efferth T (1990) P-Glykoprotein als Marker für multidrug-Resistenz in Tumoren und Normalgewebe. Tumordiagn Ther 11: 189–197
Volm M, Mattern J, Samsel, B (1991) Overexpression of P-glykoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers. Br J cancer 64: 700–704
Vos J, van Loveren H, Wester P, Vethaak D (1989) Toxic effects of environmental chemicals on the immune system. Trends Pharmacol Sci 10: 289–292
Wang Z (2001) DNA damage-induced mutagenesis: a novel target for cancer prevention. Mol Interv 1: 269–281
Watson RE, Goodman JI (2002) Epigenetics and DNA methylation come of age in toxicology. Toxicol Sci 67: 11–16
Weise A, Liehr T, Efferth T, Kuechler A, Gebhart E (2002) Comparative M-FISH and CGH analyses in sensitive and drug-resistant human T-cell acute leukaemia cell lines. Cytogenet Genome Res 98: 118–125
Wells PG, Winn LM (1996) Biochemical Toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 31: 1–40
White LK, Wright WE, Shay JW (2001) Telomerase inhibitors. Trends Biotechnol 19: 114–120
Widlak P, Pietrowska M, Lanuszewska J (2005) The role of chromatin proteins in DNA damage recognition and repair Mini-review. Histochem Cell Biol 15: 1–8
Zheng W, Aschner M, Ghersi-Egea JF (2003) Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol 192: 1–11
Zhu F, Zhang M (2003) DNA polymerase zeta: new insight into eukaryotic mutagenesis and mammalian embryonic development. World J Gastroenterol 9: 1165–1169
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2006). Molekulare Toxikologie. In: Molekulare Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48245-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-48245-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21223-2
Online ISBN: 978-3-540-48245-1
eBook Packages: Life Science and Basic Disciplines (German Language)